Sanofi Consumer Healthcare India Limited (NSE:SANOFICONR)

NSE:SANOFICONR Income Statement

Financials in millions INR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Operating Revenue	7,245	-
Other Revenue	130	-
Revenue	7,375	-
Cost of Revenue	1,861	-
Gross Profit	5,514	-
Selling, General & Admin	1,027	4.5
Other Operating Expenses	1,651	-
Operating Expenses	2,723	4.5
Operating Income	2,791	-4.5
Interest Expense	-39	-
EBT Excluding Unusual Items	2,752	-4.5
Asset Writedown	-29	-
Other Unusual Items	-255	-
Pretax Income	2,468	-4.5
Income Tax Expense	658	-
Net Income	1,810	-4.5
Net Income to Common	1,810	-4.5
Shares Outstanding (Basic)	23	2
Shares Outstanding (Diluted)	23	2
Shares Change (YoY)	1051.55%	-
EPS (Basic)	78.59	-2.25
EPS (Diluted)	78.59	-2.25
Free Cash Flow	4,291	-6
Free Cash Flow Per Share	186.31	-3.00
Dividend Per Share	55.000	-
Gross Margin	74.77%	-
Operating Margin	37.84%	-
Profit Margin	24.54%	-
Free Cash Flow Margin	58.18%	-
EBITDA	2,836	-
EBITDA Margin	38.45%	-
D&A For EBITDA	45	-
EBIT	2,791	-4.5
EBIT Margin	37.84%	-
Effective Tax Rate	26.66%	-
Revenue as Reported	7,375	-

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.